Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan M Yardley

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Addiction Biology|February 3, 2016
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory modelsMegan M Yardley, Lara A Ray
The American Journal on Addictions|January 31, 2017
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversityAnita Cservenka, Megan M Yardley, Lara A Ray
CNS Drugs|October 29, 2015
Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersMegan M Yardley, Michael M Mirbaba, Lara A Ray
Current Addiction Reports|May 11, 2016
Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersDaniel J O Roche, Lara A Ray, Megan M Yardley, et al.
Alcohol (Fayetteville, N.Y.)|June 23, 2015
Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorderMegan M Yardley, Nhat Huynh, Kathleen E Rodgers, et al.
The American Journal of Drug and Alcohol Abuse|April 21, 2017
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?Lara A Ray, Spencer Bujarski, Megan M Yardley, et al.
Neuroreport|July 9, 2014
Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humansMegan M Yardley, Michael Neely, Nhat Huynh, et al.
Neurochemical Research|March 28, 2014
Contribution of P2X4 receptors to ethanol intake in male C57BL/6 miceLetisha R Wyatt, Deborah A Finn, Sheraz Khoja, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2016
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use DisorderDaniel J O Roche, Megan M Yardley, Katy F Lunny, et al.
The International Journal of Neuropsychopharmacology|January 24, 2014
Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disordersLiana Asatryan, Megan M Yardley, Sheraz Khoja, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Addiction Biology|February 3, 2016
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory modelsMegan M Yardley, Lara A Ray
The American Journal on Addictions|January 31, 2017
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversityAnita Cservenka, Megan M Yardley, Lara A Ray
CNS Drugs|October 29, 2015
Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersMegan M Yardley, Michael M Mirbaba, Lara A Ray
Current Addiction Reports|May 11, 2016
Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersDaniel J O Roche, Lara A Ray, Megan M Yardley, et al.
Alcohol (Fayetteville, N.Y.)|June 23, 2015
Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorderMegan M Yardley, Nhat Huynh, Kathleen E Rodgers, et al.
The American Journal of Drug and Alcohol Abuse|April 21, 2017
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?Lara A Ray, Spencer Bujarski, Megan M Yardley, et al.
Neuroreport|July 9, 2014
Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humansMegan M Yardley, Michael Neely, Nhat Huynh, et al.
Neurochemical Research|March 28, 2014
Contribution of P2X4 receptors to ethanol intake in male C57BL/6 miceLetisha R Wyatt, Deborah A Finn, Sheraz Khoja, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2016
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use DisorderDaniel J O Roche, Megan M Yardley, Katy F Lunny, et al.
The International Journal of Neuropsychopharmacology|January 24, 2014
Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disordersLiana Asatryan, Megan M Yardley, Sheraz Khoja, et al.
Pageof 2